Furthermore, heterozygous mutations in NR5A2 rendered the mouse pancreas more susceptible to tissue damage, inhibited tissue regeneration, and cooperated with the mutant KRAS to promote tumor progression (35, 36). This evidence concerns the gene KRAS and neoplasm.